A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2009
11/18/2009	EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009	CN101579344A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009	CN101579343A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009	CN100560132C Contraception process and administration for same
11/18/2009	CN100560084C Method and preparations having effect against allergic symptoms
11/17/2009	US7618999 Process of obtaining taxosteroids and precursors thereof
11/17/2009	US7618959 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
11/17/2009	US7618940 Identidying modulators of hypoxia inducible factor protein for use in controlling fat metabolism and prevention and treating of obesity, diabetes and atherosclerosis
11/17/2009	US7618786 Method for identifying modulators of human orexin-2 receptor
11/17/2009	CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/17/2009	CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/17/2009	CA2398992C Therapeutic or preventive agent for pulmonary insufficiency containing a diaminotrifluoromethylpyridine derivative
11/17/2009	CA2259583C Azolo triazines and pyrimidines
11/12/2009	US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009	US20090281195 Novel cocrystallization
11/12/2009	US20090281180 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
11/12/2009	US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009	US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009	US20090281045 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
11/12/2009	US20090280120 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
11/11/2009	EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009	EP1668002B1 2,4-dioxo-3-quinazolinylaryl sulfonylureas
11/11/2009	EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009	EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/11/2009	EP1406870B1 Taxol enhancer compounds
11/11/2009	EP1317286B1 Administration form for hormonal contraception
11/11/2009	EP0831766B2 Sunscreen compositions
11/11/2009	CN101575363A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
11/11/2009	CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009	CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558409C Thiotungstate analogues and uses thereof
11/11/2009	CN100558360C Amelioration of macular degeneration and other ophthalmic diseases
11/11/2009	CN100558358C Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
11/11/2009	CN100558351C Compounds and methods for delivery of prostacyclin analogs
11/11/2009	CN100558319C Drug releasing biodegradable fiber for delivery of therapeutics
11/10/2009	US7615575 Compounds for the treatment of metabolic disorders
11/10/2009	US7615531 Methods of reducing the likelihood of spontaneous abortion
11/10/2009	CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009	CA2315262C Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
11/05/2009	US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009	US20090275645 Method to induce neovascular formation and tissue regeneration
11/05/2009	US20090275604 M3 Muscarinic Acetylcholine Receptor Antagonists
11/05/2009	US20090274717 Genes and proteins, and their use
11/05/2009	US20090274708 Recombinant Toxin Fragments
11/05/2009	US20090274654 Methods and devices for the sustained release of multiple drugs
11/05/2009	US20090274628 Reconstitutable microsphere compositions useful as ultrasonic contrast agents
11/04/2009	EP1624874B1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2009	EP1617806B1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2009	EP1615613B1 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2009	EP1311488B1 Substituted imidazoles as tafia inhibitors
11/03/2009	US7612171 DB, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/03/2009	US7612111 Esterified fatty acid composition
11/03/2009	US7612096 Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline
11/03/2009	US7612063 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
11/03/2009	CA2402222C Sustained release ranolazine formulations
11/03/2009	CA2391343C Skin care composition
11/03/2009	CA2391342C Skin care composition
10/2009
10/29/2009	US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009	US20090270446 Diamine derivatives
10/29/2009	US20090270441 Macrolides
10/29/2009	US20090269373 Saposin C-DOPS: A Novel Anti-Tumor Agent
10/28/2009	EP2112229A2 Methods for identifying risk of breast cancer and treatments thereof
10/28/2009	EP1631548B1 Inhibitors of akt activity
10/28/2009	EP0983361B1 Bacterial pheromones and uses therefor
10/28/2009	EP0651793B1 Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
10/27/2009	US7608724 Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines
10/27/2009	US7608674 Therapy for kidney diseasel removal phosphates; gastrointestinal disorders
10/27/2009	CA2495459C Selective plasma exchange therapy
10/27/2009	CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/22/2009	US20090264497 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/22/2009	US20090263427 Vaccines for mycoplasma bovis and methods of use
10/21/2009	EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009	CN101560502A Herpes virus strains for gene therapy
10/21/2009	CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/21/2009	CN100551345C Stable topical drug delivery compositions
10/20/2009	US7605273 P38 map kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
10/20/2009	US7605182 Compounds that selectively bind to membranes of apoptotic cells
10/20/2009	US7605181 Method for the treatment of metabolic disorders
10/20/2009	US7605166 Synergistic mixture of methotrexate and integrin antigen or antibody
10/20/2009	US7604979 Method for producing an L-amino acid using a bacterium with an optimized level of gene expression
10/20/2009	US7604812 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins
10/20/2009	US7604797 Compositions and methods for treating burns
10/20/2009	CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009	CA2328114C Hair colorant composition
10/15/2009	US20090260091 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders; Ccr2-deficient mice; drug screening
10/15/2009	US20090258910 benzo[1,3]dioxol-5-yl-carbamic acid 6-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester and benzo[1,3]dioxol-5-yl-carbamic acid 8-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester;
10/15/2009	US20090258821 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
10/15/2009	US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
10/14/2009	EP1658267B1 Inhibitors of cathepsin s
10/14/2009	EP1654045B1 Building element for constructing a modular substructure
10/14/2009	EP0749300B1 Pharmaceutical excipient having improved compressibility
10/14/2009	CN100548386C Releasable polymeric conjugates based on biodegradable linkers
10/14/2009	CN100548272C Composition comprising colony stimulating factor for treatment of a localized bacterial infection and bacterial related disease
10/13/2009	US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009	US7601731 Antimicrobial flush solutions
10/13/2009	US7601719 Compounds, methods and pharmaceutical compositions for inhibiting PARP
10/13/2009	US7601695 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal
10/13/2009	US7601694 Inhibiting angiogenesis, tumor growth and metastasis in the tissue of a mammal by administering to the mammal an active agent comprising an angiogenesis-inhibiting amount of a selective antagonist of denatured collagen type-IV
10/13/2009	US7601332 Vitamin receptor binding drug delivery conjugates

1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 295